Nadia Emi Aikawa, MD, PhD (she/her/hers)

Rheumatology Division, University of Sao Paulo
Sao Paulo, São Paulo, Brazil

Attending Physician

Presentation(s):

• 0206: Prospective Controlled Study of Humoral Response to Recombinant Zoster Vaccine in Cyclophosphamide-Treated Autoimmune Rheumatic Disease Patients: No Additional Impairment Compared to Other Immunosuppressive Therapies

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): GlaxoSmithKlein(GSK): Grant/Research Support (Ongoing)

• 2573: Impaired Humoral Response to Recombinant Herpes Zoster Vaccine in Rituximab Treated Autoimmune Rheumatic Diseases Patients: A Prospective Controlled Phase 4 Study

  Tuesday, October 28, 2025
  1:00 PM - 1:15 PM Central Time

  Disclosure(s): GlaxoSmithKlein(GSK): Grant/Research Support (Ongoing)